Menu
Your Cart

Vigamoks cap. eye. 0.5% fl. 5 ml

Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
Vigamoks cap. eye. 0.5% fl. 5 ml
$29.02
  • Stock: In Stock
  • Model: 179598

0% Customers recommend this product

  • 5 Awesome
    0%
  • 4 Great
    0%
  • 3 Average
    0%
  • 2 Bad
    0%
  • 1 Poor
    0%

Reviews Over Vigamoks cap. eye. 0.5% fl. 5 ml

  • (0)

Total Reviews (0)
click here write review to add review for this product.



Description

Drops eye Vigamoks of 0.5% are shown for topical treatment of the bacterial conjunctivitis caused by strains of bacteria, sensitive to a moksifloksatsin. For obtaining information of rather corresponding use of antibacterial agents you watch official installations.

Structure

Active ingredient: 1 ml of a moksifloksatsin of a hydrochloride of 5.45 mg that is equivalent to 5 mg of a moksifloksatsin;

Excipients: sodium chloride, boric acid, sodium hydroxide and/or the hydrochloric acid concentrated (for regulation rn), the water purified.

Contraindication

Hypersensitivity to active agent, other hinolon or to any of medicine components.

Route of administration

For ophthalmologic application.

Adult, including patients of advanced age

to Dig in on 1 drop in the affected eye (eyes) 3 times a day.

Usually the state improves within 5 days then it is necessary to continue treatment even the next 2-3 days. If within 5 days of the carried-out treatment of improvement it is not observed, it is necessary to consult with the doctor for specification of the diagnosis and/or treatment. Duration of treatment depends on severity of a disease and on a clinical and bacteriological picture of a course of the disease.

Feature of application

Pregnant

Vigamoks should not be applied during pregnancy unless the potential advantage of use of medicine exceeds potential risk for a fruit.

Children

during clinical trials of Vigamoks, it was to children, safe at application, including newborns.

Drivers

With care.

Overdose

Considering characteristics of medicine, the toxic effect in case of overdose at use of medicine in eyes is not expected or at accidental swallowing contents of one bottle.

Side effects

during clinical trials by the most widespread side reactions were eye pain and irritation of an eye which arose approximately in 1% - 2% of patients.

Interaction

by

If are at the same time appointed by several ophthalmologic medicines for topical administration, the interval between their applications has to make not less than 5 minutes. Oculentums should be applied the last.

Storage conditions

Special storage conditions of medicine are not provided by

.

to Store

in the places inaccessible for children.

Expiration date - 3 years.

Specifications

Characteristics
Active ingredients Moxifloxacin
Amount of active ingredient 5 mg/ml
Applicant Alcon
Code of automatic telephone exchange S01AE07 Moxifloxacin
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status The branded generic
Origin Chemical
Prescription status According to the prescription
Primary packing bottle
Producer ALKON-KUVROR
Quantity in packing 5 ml
Release form eye drops
Route of administration Eye
Sign Import
Storage temperature from 2 °C to 25 °C
Trade name Vigamoks